About Haemonetics Corporation Common Stock Company overview from Wikipedia

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

History

The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.

In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.

Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.

On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.

Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.

In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.

Product categories

Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.

Hemostasis

TEG 5000

Kaolin TEG

Kaolin TEG with Heparinase

RapidTEG

TEG Functional Fibrinogen

TEG PlateletMapping

TEG 6S

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

HAE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$107.74

Market Cap

$4.88B

P/E (TTM)

52.6

EPS (TTM)

$2.05

Revenue (TTM)

$1.33B

Div Yield

—

ROE

11.8%

Debt/Equity

1.5

52W Range

$47 – $109

HAE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $1.33B

2017-04-01 → 2026-03-28

EPS $2.05

2017-04-01 → 2026-03-28

Free Cash Flow $260M

2017-04-01 → 2026-03-28

Margins 7.3%

2017-04-01 → 2026-03-28

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

HAE

Peer Median

P/E (TTM)

52.6

39.4

P/S (TTM)

3.7

2.1

P/B

6.1

3.3

EV / EBITDA

37.4

—

Price / FCF

18.7

—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

HAE

Peer Median

Gross Margin

59.0%

58.7%

Operating Margin

11.8%

—

Net Profit Margin

7.3%

-11.8%

ROA

4.0%

-6.3%

ROE

11.8%

-13.4%

ROIC

5.9%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

HAE

Peer Median

Debt / Equity

1.5

37.4

Current Ratio

3.0

2.4

Quick Ratio

1.6

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

HAE

Peer Median

Revenue YoY

-2.0%

—

Revenue CAGR 3Y

4.5%

—

Revenue CAGR 5Y

8.9%

—

EPS YoY

-38.1%

—

Net Income YoY

-42.0%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

HAE

Peer Median

EPS (Diluted)

$2.05

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

HAE

Peer Median

HAE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 15 analysts

Strong Buy 5 33.3%
Buy 6 40.0%
Hold 4 26.7%
Sell 0 0.0%
Strong Sell 0 0.0%

12-Month Price Target

10 analysts · 2026-08-20

Median $104.50

Now $107.74

Low $86.00

High $120.00

Median target $104.50 -3.0%

Mean target $104.10 -3.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

0.06%

Period	EPS Actual	EPS Est	Surprise
March 31, 2027	$1.14	$1.09	0.05%
June 30, 2026	$1.14	$1.09	0.05%
March 31, 2026	$1.29	$1.28	0.01%
Dec. 31, 2025	$1.31	$1.26	0.05%
Sept. 30, 2025	$1.27	$1.12	0.15%
June 30, 2025	$1.10	$1.03	0.07%
March 31, 2025	$1.24	$1.23	0.01%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
HAE	$2.45B	26.4	-2.0%	7.3%	11.8%	59.0%
COO	$13.70B	37.4	5.1%	9.2%	4.6%	65.5%
ALGN	$11.14B	27.6	0.90%	10.2%	10.3%	67.2%
LNTH	$4.30B	19.5	0.50%	15.2%	20.7%	61.1%
MMED	$3.71B	-10.2	14.2%	-10.7%	-9.3%	54.2%
MMSI	$5.24B	41.4	11.8%	8.5%	8.4%	48.7%
ICUI	$3.52B	4755.7	-6.3%	0.03%	0.03%	36.8%
QDEL	$1.99B	-1.8	-1.9%	-41.4%	-48.0%	—
XRAY	$2.28B	-3.8	-3.0%	-16.2%	-36.4%	50.0%
NEOG	$1.95B	-224.2	-2.7%	-0.91%	-0.38%	46.9%
UFPT	$1.71B	25.4	19.5%	11.3%	16.9%	28.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16

Annual Income Statement data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$1.33B	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M
Cost of Revenue	$546M	$612M	$618M	$554M	$488M	$473M	$504M	$550M	$492M	$508M	$503M	$476M
Gross Profit	$788M	$749M	$692M	$615M	$506M	$398M	$485M	$418M	$412M	$378M	$406M	$434M
R&D Expense	$60M	$63M	$54M	$50M	$47M	$33M	$31M	$36M	$39M	$38M	$45M	$54M
SG&A Expense	$442M	$437M	$430M	$377M	$340M	$275M	$282M	$273M	$317M	$302M	$317M	$337M
Operating Expenses	$631M	$527M	$527M	$459M	$425M	$308M	$381M	$334M	$356M	$398M	$450M	$394M
Operating Income	$157M	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M
Other Non-op	$-29M	$-10M	$-13M	$-15M	$-17M	$-17M	$-16M	$-10M	$-5M	$-8M	$-9M	$-9M
Pretax Income	$128M	$212M	$152M	$141M	$64M	$73M	$87M	$74M	$60M	$-27M	$-53M	$31M
Income Tax	$31M	$44M	$34M	$26M	$20M	$-7M	$11M	$19M	$14M	$-1M	$2M	$14M
Net Income	$97M	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M
EPS (Basic)	$2.06	$3.33	$2.32	$2.27	$0.85	$1.57	$1.51	$1.07	$0.86	$-0.51	$-1.09	$0.33
EPS (Diluted)	$2.05	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32
Shares (Basic)	47,179,000	50,330,000	50,706,000	50,783,000	51,047,000	50,688,000	50,692,000	51,533,000	52,755,000	51,524,000	50,910,000	51,533,000
Shares (Diluted)	47,354,000	50,730,000	51,397,000	51,420,000	51,353,000	51,292,000	51,815,000	52,942,000	53,501,000	51,524,000	50,910,000	52,089,000
EBITDA	$157M	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M

Balance Sheet 25

Annual Balance Sheet data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$245M	$307M	$179M	$284M	$259M	$192M	$137M	$169M	$180M	$140M	$115M	$161M
Receivables	$217M	$203M	$207M	$179M	$159M	$128M	$165M	$185M	$151M	$153M	$157M	$146M
Inventory	$306M	$365M	$317M	$259M	$293M	$323M	$270M	$194M	$161M	$177M	$187M	$211M
Prepaid Expense	$66M	$60M	$66M	$47M	$44M	$51M	$31M	$27M	$29M	$41M	$29M	$40M
Current Assets	$835M	$935M	$769M	$770M	$756M	$694M	$604M	$576M	$521M	$510M	$488M	$558M
PP&E (Net)	$306M	$284M	$311M	$311M	$258M	$218M	$253M	$344M	$332M	$324M	$338M	$322M
PP&E (Gross)	$842M	$837M	$959M	$944M	$869M	$817M	$832M	$933M	$873M	$807M	$786M	$732M
Accum. Depreciation	$536M	$553M	$648M	$633M	$611M	$600M	$579M	$589M	$541M	$484M	$449M	$410M
Goodwill	$656M	$604M	$565M	$466M	$467M	$466M	$211M	$211M	$211M	$211M	$268M	$334M
Intangibles	$448M	$456M	$406M	$276M	$310M	$365M	$133M	$128M	$157M	$178M	$204M	$245M
Other Non-current Assets	$142M	$164M	$136M	$107M	$63M	$71M	$62M	$12M	$12M	$12M	$14M	$11M
Total Assets	$2.40B	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B
Accounts Payable	$51M	$67M	$73M	$64M	$58M	$50M	$51M	$63M	$55M	$43M	$40M	$48M
Current Liabilities	$283M	$578M	$300M	$252M	$442M	$253M	$275M	$236M	$385M	$211M	$186M	$189M
Capital Leases	$41M	$50M	$58M	$56M	$56M	$63M	$52M	·	·	·	·	·
Deferred Tax	$38M	$63M	$63M	$36M	$29M	$44M	$11M	$20M	$7M	$12M	$21M	$33M
Other Non-current Liabilities	$59M	$68M	$75M	$75M	$80M	$100M	$89M	$29M	$34M	$22M	$26M	$32M
Long-term Debt	$1.24B	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$316M	$408M	$430M
Total Debt	$1.22B	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$315M	$408M	$428M
Common Stock	$453.0K	$482.0K	$508.0K	$504.0K	$511.0K	$509.0K	$503.0K	$510.0K	$523.0K	$523.0K	$509.0K	$517.0K
Retained Earnings	$279M	$352M	$360M	$253M	$202M	$158M	$79M	$161M	$267M	$290M	$316M	$420M
AOCI	$-38M	$-55M	$-36M	$-30M	$-26M	$-30M	$-45M	$-30M	$-19M	$-33M	$-35M	$-22M
Stockholders' Equity	$796M	$821M	$960M	$818M	$749M	$732M	$587M	$668M	$752M	$740M	$722M	$826M
Liabilities + Equity	$2.40B	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B
Shares Outstanding	45,252,667	48,215,899	50,787,859	50,448,519	51,124,240	50,868,820	50,322,930	51,019,918	52,342,965	52,255,495	50,932,348	51,670,969

Cash Flow 16

Annual Cash Flow data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
D&A	$112M	$116M	$97M	$93M	$98M	$84M	$110M	$109M	$89M	$90M	$90M	$86M
Stock-based Comp	$34M	$30M	$28M	$26M	$24M	$26M	$20M	$17M	$13M	$9M	$7M	$14M
Deferred Tax	$-26M	$-6M	$-11M	$6M	$5M	$-21M	$-7M	$13M	$-6M	$-7M	$-1M	$4M
Amort. of Intangibles	$50M	$56M	$41M	$42M	$57M	$41M	$34M	$25M	$32M	$37M	$59M	$34M
Restructuring	$3M	$14M	$14M	$657.0K	$4M	$1M	$4M	$395.0K	$31M	$22M	$23M	$37M
Operating Cash Flow	$293M	$182M	$182M	$273M	$172M	$109M	$158M	$159M	$220M	$160M	$122M	$127M
CapEx	$33M	$39M	$38M	$191M	$97M	$37M	$49M	$119M	$75M	$76M	$102M	$122M
Investing Cash Flow	$-180M	$-162M	$-322M	$-144M	$-86M	$-425M	$-57M	$-116M	$-63M	$-73M	$-105M	$-122M
Debt Issued	·	·	·	·	·	·	$0	$348M	$0	$0	·	$0
Net Debt Issued	·	$-5M	$-12M	$-10M	$-18M	$-22M	$-13M	$81M	$-62M	$-43M	$-21M	$-9M
Stock Repurchased	$175M	$225M	$0	$75M	$0	$0	$175M	$160M	$100M	$0	$61M	$39M
Net Stock Activity	$-175M	$-225M	$0	$-75M	$0	$0	$-175M	$-160M	$-100M	$0	$-61M	$-39M
Financing Cash Flow	$-178M	$109M	$38M	$-100M	$-16M	$367M	$-131M	$-51M	$-121M	$-60M	$-63M	$-33M
Net Change in Cash	$-61M	$128M	$-106M	$25M	$67M	$55M	$-32M	$-11M	$41M	$24M	$-46M	$-32M
Taxes Paid	$61M	·	·	·	·	$12M	$12M	$8M	$9M	$7M	$8M	$11M
Free Cash Flow	$260M	$142M	$115M	$163M	$76M	$72M	$109M	$40M	$146M	$84M	$19M	$5M

Profitability 8

Annual Profitability data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Gross Margin	59.0%	55.0%	52.8%	52.6%	50.9%	45.7%	49.0%	43.1%	45.6%	42.7%	44.7%	47.7%
Operating Margin	11.8%	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%
Net Margin	7.3%	12.3%	9.0%	9.9%	4.4%	9.1%	7.7%	5.7%	5.0%	-3.0%	-6.1%	1.9%
Pretax Margin	9.6%	15.6%	11.6%	12.1%	6.4%	8.4%	8.8%	7.6%	6.6%	-3.1%	-5.9%	3.4%
EBITDA Margin	11.8%	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%
ROA	4.0%	7.2%	5.7%	6.1%	2.4%	5.1%	6.0%	4.4%	3.7%	-2.1%	-4.0%	1.1%
ROE	11.8%	19.4%	12.3%	14.5%	5.9%	11.0%	13.2%	8.7%	6.1%	-3.6%	-7.2%	2.0%
ROIC	5.9%	8.6%	7.2%	8.0%	3.6%	6.8%	9.4%	6.1%	4.3%	-1.8%	-4.0%	1.8%

Liquidity & Solvency 4

Annual Liquidity & Solvency data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio	3.0	1.6	2.6	3.1	1.7	2.7	2.2	2.4	1.4	2.4	2.6	3.0
Quick Ratio	1.6	0.9	1.3	1.8	0.9	1.3	1.1	1.5	0.9	1.4	1.5	1.6
Debt / Equity	1.5	1.5	0.8	0.9	1.0	1.0	0.7	0.5	0.3	0.4	0.6	0.5
LT Debt / Equity	1.5	1.1	0.8	0.9	0.7	0.9	0.5	0.5	0.1	0.3	0.5	0.5

Efficiency 3

Annual Efficiency data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover	0.6	0.6	0.6	0.6	0.5	0.6	0.8	0.8	0.7	0.7	0.6	0.6
Inventory Turnover	1.6	1.8	2.1	2.0	1.6	1.6	2.2	3.1	2.9	2.8	2.5	2.3
Receivables Turnover	6.4	6.7	6.8	6.9	6.9	5.9	5.6	5.8	5.9	5.7	6.0	5.9

Per Share 5

Annual Per Share data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	$17.60	$17.02	$18.90	$16.21	$14.66	$14.38	$11.67	$13.09	$14.38	$14.15	$14.17	$15.99
Revenue / Share	$28.17	$26.82	$25.47	$22.73	$19.34	$16.97	$19.08	$18.28	$16.90	$17.20	$17.85	$17.48
Cash Flow / Share	$6.19	$3.58	$3.54	$5.31	$3.35	$2.12	$3.05	$3.01	$4.12	$3.10	$2.39	$2.44
Cash / Share	$5.42	$6.36	$3.52	$5.64	$5.08	$3.78	$2.73	$3.32	$3.44	$2.67	$2.26	$3.11
EPS (TTM)	$2.05	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32

Growth Rates 9

Annual Growth Rates data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	-2.0%	4.0%	12.0%	17.7%	14.1%	·	·	·	·	·	·	·
Revenue CAGR 3Y	4.5%	11.1%	14.6%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	8.9%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-38.1%	44.5%	2.2%	166.7%	-45.8%	·	·	·	·	·	·	·
EPS CAGR 3Y	-2.9%	58.0%	13.9%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	5.8%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-42.0%	42.6%	1.9%	166.1%	-45.4%	·	·	·	·	·	·	·
Net Income CAGR 3Y	-5.5%	56.9%	13.9%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	4.1%	·	·	·	·	·	·	·	·	·	·	·

Valuation (TTM) 14

Annual Valuation (TTM) data for HAE
Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$1.33B	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M
Net Income TTM	$97M	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M
Market Cap	$2.45B	$3.05B	$4.33B	$4.17B	$3.26B	$5.70B	$5.08B	$4.46B	$3.83B	$2.12B	$1.80B	$2.28B
Enterprise Value	$3.42B	$3.96B	$4.96B	$4.66B	$3.78B	$6.21B	$5.33B	$4.64B	$3.90B	$2.30B	$2.09B	$2.55B
P/E	26.4	19.1	37.3	36.9	76.0	72.3	68.2	84.1	86.1	-79.5	-32.4	138.2
P/S	1.8	2.2	3.3	3.6	3.3	6.5	5.1	4.6	4.2	2.4	2.0	2.5
P/B	3.1	3.7	4.5	5.1	4.4	7.8	8.7	6.7	5.1	2.9	2.5	2.8
P / Tangible Book	·	·	·	54.9	·	·	·	·	·	·	·	·
P / Cash Flow	8.3	16.8	23.8	15.3	18.9	52.4	32.1	28.0	17.4	13.3	14.7	18.0
P / FCF	9.4	21.4	37.5	25.6	43.1	79.4	46.4	110.7	26.3	25.4	92.4	460.7
EV / EBITDA	21.8	17.9	30.1	29.8	46.8	69.2	51.5	55.6	69.5	-118.4	-47.6	62.9
EV / FCF	13.1	27.8	43.0	28.6	49.9	86.6	48.7	115.2	26.8	27.5	107.4	514.6
EV / Revenue	2.6	2.9	3.8	4.0	3.8	7.1	5.4	4.8	4.3	2.6	2.3	2.8
Earnings Yield	3.8%	5.2%	2.7%	2.7%	1.3%	1.4%	1.5%	1.2%	1.2%	-1.3%	-3.1%	0.72%

Income Statement 16

Quarterly Income Statement data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Revenue	$339M	$346M	$339M	$327M	$321M	$331M	$349M	$346M	$336M	$343M	$336M	$318M	$340M	$305M	$297M
Cost of Revenue	$137M	$148M	$137M	$133M	$129M	$138M	$155M	$158M	$161M	$167M	$158M	$148M	$169M	$147M	$140M
Gross Profit	$203M	$198M	$202M	$195M	$192M	$193M	$194M	$187M	$175M	$176M	$178M	$171M	$172M	$159M	$158M
R&D Expense	$16M	$14M	$14M	$15M	$16M	$18M	$16M	$14M	$14M	$16M	$13M	$13M	$16M	$13M	$11M
SG&A Expense	$119M	$121M	$109M	$102M	$111M	$115M	$106M	$107M	$108M	$109M	$112M	$115M	$98M	$95M	$92M
Operating Expenses	$145M	$221M	$135M	$136M	$138M	$122M	$135M	$136M	$135M	$146M	$132M	$135M	$121M	$115M	$111M
Operating Income	$57M	$-23M	$67M	$58M	$54M	$71M	$59M	$52M	$40M	$30M	$46M	$35M	$51M	$43M	$47M
Other Non-op	$-10M	$-5M	$-7M	$-7M	$-9M	$-598.0K	$-9M	$-7M	$7M	$-7M	$-2M	$-2M	$-3M	$-1M	$-6M
Pretax Income	$48M	$-28M	$60M	$51M	$45M	$71M	$50M	$45M	$47M	$23M	$44M	$33M	$48M	$42M	$41M
Income Tax	$15M	$-8M	$15M	$13M	$11M	$13M	$12M	$11M	$8M	$3M	$13M	$8M	$5M	$9M	$8M
Net Income	$33M	$-20M	$45M	$39M	$34M	$58M	$37M	$34M	$38M	$20M	$31M	$25M	$42M	$33M	$33M
EPS (Basic)	$0.73	$-0.42	$0.96	$0.81	$0.71	$1.17	$0.75	$0.66	$0.75	$0.40	$0.62	$0.49	$0.84	$0.65	$0.65
EPS (Diluted)	$0.72	$-0.41	$0.95	$0.81	$0.70	$1.17	$0.74	$0.66	$0.74	$0.40	$0.61	$0.48	$0.84	$0.64	$0.64
Shares (Basic)	45,361,000	-95,314,000	46,792,000	47,590,000	48,111,000	-101,797,000	50,286,000	50,898,000	50,943,000	27,000	50,768,000	50,727,000	-102,174,000	50,509,000	50,953,000
Shares (Diluted)	45,704,000	-95,650,000	46,987,000	47,664,000	48,353,000	-102,713,000	50,639,000	51,240,000	51,564,000	3,000	51,445,000	51,396,000	-103,165,000	51,219,000	51,558,000
EBITDA	$57M	·	$67M	$58M	$54M	·	$59M	$52M	$40M	·	$46M	$35M	·	$43M	$47M

Balance Sheet 25

Quarterly Balance Sheet data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Cash & Equivalents	$223M	$245M	$363M	$296M	$293M	$307M	$321M	$299M	$344M	$179M	$194M	$351M	·	$224M	$241M
Receivables	$216M	$217M	$196M	$207M	$201M	$203M	$212M	$214M	$201M	$207M	$212M	$174M	·	$181M	$172M
Inventory	$307M	$306M	$321M	$336M	$361M	$365M	$360M	$382M	$374M	$317M	$304M	$286M	·	$256M	$255M
Prepaid Expense	$65M	$66M	$63M	$60M	$59M	$60M	$113M	$61M	$59M	$66M	$55M	$55M	·	$45M	$48M
Current Assets	$811M	$835M	$944M	$900M	$913M	$935M	$1.01B	$956M	$979M	$769M	$765M	$866M	·	$706M	$716M
PP&E (Net)	$304M	$306M	$297M	$292M	$287M	$284M	$286M	$300M	$302M	$311M	$319M	$308M	·	$313M	$308M
PP&E (Gross)	$854M	$842M	$837M	$815M	$795M	$837M	$867M	$939M	$949M	$959M	$979M	$950M	·	·	·
Accum. Depreciation	$550M	$536M	$540M	$523M	$508M	$553M	$581M	$639M	$647M	$648M	$661M	$642M	·	·	·
Goodwill	$657M	$656M	$607M	$606M	$607M	$604M	$605M	$616M	$613M	$565M	$555M	$465M	$466M	$466M	$465M
Intangibles	$435M	$448M	$420M	$428M	$451M	$456M	$466M	$488M	$495M	$406M	$429M	$251M	·	$284M	$293M
Other Non-current Assets	$150M	$142M	$216M	$208M	$196M	$164M	$160M	$156M	$142M	$136M	$127M	$117M	·	$103M	$80M
Total Assets	$2.37B	$2.40B	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	·	$1.88B	$1.87B
Accounts Payable	$56M	$51M	$49M	$62M	$46M	$67M	$63M	$69M	$77M	$73M	$57M	$80M	·	$64M	$61M
Current Liabilities	$263M	$283M	$540M	$548M	$531M	$578M	$253M	$274M	$260M	$300M	$262M	$264M	·	$227M	$262M
Capital Leases	·	$41M	·	·	·	$50M	·	·	·	$58M	·	·	·	·	·
Deferred Tax	$39M	$38M	$56M	$58M	$59M	$63M	$61M	$63M	$65M	$63M	$62M	$35M	·	$40M	$36M
Other Non-current Liabilities	$57M	$59M	$64M	$66M	$68M	$68M	$90M	$90M	$92M	$75M	$76M	$70M	·	$78M	$78M
Long-term Debt	$1.19B	$1.24B	$1.22B	$1.22B	$1.22B	$1.25B	$1.22B	$1.22B	$1.22B	$808M	$871M	$762M	·	$767M	$818M
Total Debt	$1.17B	·	$1.22B	$1.22B	$1.22B	·	$1.22B	$1.22B	$1.22B	·	$871M	$762M	·	$767M	$818M
Common Stock	$455.0K	$453.0K	$468.0K	$467.0K	$482.0K	$482.0K	$502.0K	$504.0K	$512.0K	$508.0K	$508.0K	$507.0K	·	$504.0K	$506.0K
Retained Earnings	$312M	$279M	$381M	$336M	$356M	$352M	$392M	$369M	$387M	$360M	$340M	$309M	·	$224M	$204M
AOCI	$-42M	$-38M	$-35M	$-41M	$-36M	$-55M	$-56M	$-35M	$-43M	$-36M	$-24M	$-33M	·	$-36M	$-40M
Stockholders' Equity	$837M	$796M	$911M	$849M	$882M	$821M	$907M	$879M	$905M	$960M	$943M	$894M	$818M	$776M	$729M
Liabilities + Equity	$2.37B	$2.40B	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	·	$1.88B	$1.87B
Shares Outstanding	45,471,313	45,252,667	46,829,249	46,747,381	48,158,723	48,215,899	50,235,051	50,381,127	51,152,886	50,787,859	50,785,040	50,740,389	·	50,444,470	50,605,499

Cash Flow 13

Quarterly Cash Flow data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
D&A	$27M	$27M	$27M	$28M	$29M	$28M	$29M	$29M	$29M	$28M	$24M	·	$24M	$24M	·
Stock-based Comp	$9M	$9M	$8M	$8M	$9M	$7M	$8M	$7M	$8M	$7M	$7M	·	$7M	$7M	·
Deferred Tax	$668.0K	$-20M	$-2M	$-725.0K	$-3M	$3M	$-2M	$-2M	$-4M	$-6M	$-3M	·	·	·	·
Amort. of Intangibles	$12M	$12M	$12M	$13M	$13M	$13M	$14M	$14M	$14M	$13M	$9M	$9M	$15M	$10M	$11M
Restructuring	$2M	$196.0K	$1M	$204.0K	$1M	$984.0K	$4M	$5M	$5M	$6M	$8M	$86.0K	$701.0K	$44.0K	$165.0K
Operating Cash Flow	$52M	$71M	$94M	$111M	$17M	$117M	$44M	$49M	$-27M	$64M	$-540.0K	·	$80M	$64M	·
CapEx	$8M	$18M	$6M	$5M	$4M	$16M	$9M	$9M	$6M	$7M	$-3M	·	$93M	$17M	·
Investing Cash Flow	$-22M	$-87M	$-29M	$-30M	$-33M	$18M	$-17M	$-23M	$-139M	$-13M	$-269M	·	$-18M	$-36M	·
Net Debt Issued	$-2M	·	·	·	$-2M	·	·	·	$-2M	·	·	·	·	·	·
Stock Repurchased	·	$100M	$0	·	·	$150M	$0	·	·	$0	$0	·	$0	$0	·
Financing Cash Flow	$-52M	$-101M	$2M	$-77M	$-2M	$-151M	$1M	$-75M	$334M	$-64M	$109M	·	$-2M	$-50M	·
Net Change in Cash	$-22M	$-118M	$67M	$4M	$-14M	$-14M	$22M	$-45M	$166M	$-15M	$-157M	·	$60M	$-17M	·
Free Cash Flow	$44M	·	·	·	$14M	·	·	·	$-33M	·	·	·	·	·	·

Profitability 8

Quarterly Profitability data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Gross Margin	59.8%	·	59.7%	59.5%	59.8%	·	55.5%	54.2%	52.0%	·	52.9%	53.6%	·	52.0%	53.1%
Operating Margin	16.9%	·	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	·	14.2%	15.7%
Net Margin	9.7%	·	13.2%	11.8%	10.6%	·	10.8%	9.8%	11.4%	·	9.3%	7.8%	·	10.8%	11.2%
Pretax Margin	14.0%	·	17.7%	15.7%	14.1%	·	14.3%	12.9%	13.9%	·	13.1%	10.3%	·	13.8%	13.8%
EBITDA Margin	16.9%	·	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	·	14.2%	15.7%
ROA	1.4%	·	1.8%	1.6%	1.4%	·	1.6%	1.5%	1.7%	·	1.5%	1.3%	·	1.8%	1.8%
ROE	3.8%	·	4.9%	4.5%	3.8%	·	4.0%	3.8%	4.3%	·	3.6%	3.1%	·	4.4%	4.7%
ROIC	2.0%	·	2.4%	2.1%	1.9%	·	2.1%	1.9%	1.5%	·	1.8%	1.6%	·	2.2%	2.4%

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Current Ratio	3.1	·	1.7	1.6	1.7	·	4.0	3.5	3.8	·	2.9	3.3	·	3.1	2.7
Quick Ratio	1.7	·	1.0	0.9	0.9	·	2.1	1.9	2.1	·	1.5	2.0	·	1.8	1.6
Debt / Equity	1.4	·	1.3	1.4	1.4	·	1.4	1.4	1.4	·	0.9	0.9	·	1.0	1.1
LT Debt / Equity	1.4	·	1.0	1.1	1.0	·	1.3	1.4	1.3	·	0.9	0.8	·	1.0	1.0

Efficiency 3

Quarterly Efficiency data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Asset Turnover	0.1	·	0.1	0.1	0.1	·	0.1	0.2	0.1	·	0.2	0.2	·	0.2	0.2
Inventory Turnover	0.4	·	0.4	0.4	0.4	·	0.5	0.5	0.5	·	0.6	0.5	·	0.5	0.5
Receivables Turnover	1.6	·	1.7	1.6	1.6	·	1.6	1.8	1.8	·	1.7	1.8	·	1.8	1.9

Per Share 5

Quarterly Per Share data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Book Value / Share	$18.41	·	$19.46	$18.17	$18.32	·	$18.05	$17.44	$17.70	·	$18.57	$17.61	·	$15.38	$14.41
Revenue / Share	$7.43	·	$7.21	$6.87	$6.65	·	$6.88	$6.74	$6.52	·	$6.54	$6.19	·	$5.96	$5.77
Cash Flow / Share	$1.14	·	·	·	$0.36	·	·	·	$-0.53	·	·	·	·	·	·
Cash / Share	$4.91	·	$7.76	$6.34	$6.08	·	$6.39	$5.94	$6.73	·	$3.82	$6.92	·	$4.44	$4.77
EPS (TTM)	$3.18	·	$3.20	$2.91	$2.84	·	$2.75	$2.49	$2.63	·	$2.53	$2.56	·	·	·

Valuation (TTM) 14

Quarterly Valuation (TTM) data for HAE
Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Revenue TTM	$1.33B	·	$1.34B	$1.34B	$1.35B	·	$1.37B	$1.34B	$1.30B	·	$1.27B	$1.23B	·	·	·
Net Income TTM	$150M	·	$155M	$144M	$144M	·	$141M	$128M	$136M	·	$130M	$132M	·	·	·
Market Cap	$3.51B	·	$3.76B	$2.25B	$3.55B	·	$3.90B	$4.02B	$4.23B	·	$4.34B	$4.55B	·	$3.97B	$3.75B
Enterprise Value	$4.47B	·	$4.62B	$3.18B	$4.49B	·	$4.80B	$4.95B	$5.11B	·	$5.02B	$4.96B	·	$4.51B	$4.32B
P/E	24.3	·	25.1	16.6	26.0	·	28.2	32.0	31.5	·	33.8	35.0	·	·	·
P/S	2.6	·	2.8	1.7	2.6	·	2.9	3.0	3.3	·	3.4	3.7	·	·	·
P/B	4.2	·	4.1	2.7	4.0	·	4.3	4.6	4.7	·	4.6	5.1	·	5.1	5.1
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	25.6	·	155.7	·
P / Cash Flow	67.2	·	·	·	204.3	·	·	·	-154.3	·	·	·	·	·	·
P / FCF	79.1	·	·	·	260.5	·	·	·	-127.9	·	·	·	·	·	·
EV / EBITDA	77.7	·	68.6	54.4	83.3	·	81.3	95.7	128.6	·	109.2	140.4	·	104.2	92.5
EV / FCF	100.5	·	·	·	328.9	·	·	·	-154.5	·	·	·	·	·	·
EV / Revenue	3.4	·	3.5	2.4	3.3	·	3.5	3.7	3.9	·	3.9	4.0	·	·	·
Earnings Yield	4.1%	·	4.0%	6.0%	3.9%	·	3.5%	3.1%	3.2%	·	3.0%	2.9%	·	·	·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Revenue	$1.33B	$1.36B	$1.31B	$1.17B	$993M
Gross Margin %	59.0%	55.0%	52.8%	52.6%	50.9%
Operating Margin %	11.8%	16.3%	12.6%	13.4%	8.1%
Net Income	$97M	$168M	$118M	$115M	$43M
Diluted EPS	$2.05	$3.31	$2.29	$2.24	$0.84

Balance Sheet

	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Debt / Equity	1.5	1.5	0.8	0.9	1.0
Current Ratio	3.0	1.6	2.6	3.1	1.7
Quick Ratio	1.6	0.9	1.3	1.8	0.9

Cash Flow

	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Free Cash Flow	$260M	$142M	$115M	$163M	$76M

Latest News Recent headlines mentioning this company

Haemonetics Q4 Earnings Call Highlights Yahoo Finance · 3 months, 1 week ago
Riverwater Sustainable Value Strategy Awaits Haemonetics Corporation’s (HAE) Market Validation Yahoo Finance · 3 months, 4 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 363 filers · $2.6B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
56 (-3 vs prior Q)	43 (-12 vs prior Q)	111 (-2 vs prior Q)	114 (-1 vs prior Q)	+1.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
VANGUARD GROUP INC	$349,945,961	4,366,138	13.44%	Shares
NEUBERGER BERMAN GROUP LLC	$308,172,249	4,108,761	11.84%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$190,979,550	2,546,394	7.34%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$154,468,350	2,059,578	5.93%	Shares
STATE STREET CORP	$136,363,950	1,818,186	5.24%	Shares
CITADEL ADVISORS LLC	$113,259,000	1,510,120	4.35%	Shares
DIMENSIONAL FUND ADVISORS LP	$109,143,975	1,455,253	4.19%	Shares
River Road Asset Management, LLC	$96,420,150	1,285,602	3.70%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$86,651,325	1,155,351	3.33%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$79,315,930	1,057,321	3.05%	Shares
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/	$62,319,375	830,925	2.39%	Shares
GOLDMAN SACHS GROUP INC	$52,644,150	701,922	2.02%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$44,356,725	591,423	1.70%	Shares
MILLENNIUM MANAGEMENT LLC	$42,780,975	570,413	1.64%	Shares
Holocene Advisors, LP	$41,264,625	550,195	1.58%	Shares
SILVERCREST ASSET MANAGEMENT GROUP LLC	$37,034,909	493,796	1.42%	Shares
North Peak Capital Management, LLC	$25,730,775	343,077	0.99%	Shares
LONDON CO OF VIRGINIA	$25,543,299	340,574	0.98%	Shares
DEUTSCHE BANK AG\	$25,282,575	337,101	0.97%	Shares
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	$24,905,625	332,075	0.96%	Shares
VANGUARD FIDUCIARY TRUST CO	$24,779,850	330,398	0.95%	Shares
Boston Trust Walden Corp	$24,170,475	322,273	0.93%	Shares
Aristotle Capital Boston, LLC	$21,721,809	289,624	0.83%	Shares
MIZUHO MARKETS AMERICAS LLC	$21,166,050	282,214	0.81%	Shares
BANK OF AMERICA CORP /DE/	$20,122,875	268,305	0.77%	Shares
Invenomic Capital Management LP	$16,216,275	216,217	0.62%	Shares
FMR LLC	$15,638,325	208,511	0.60%	Shares
HEARTLAND ADVISORS INC	$15,000,000	200,000	0.58%	Shares
GLENMEDE TRUST CO NA	$14,454,000	192,720	0.56%	Shares
MORGAN STANLEY	$13,073,475	174,313	0.50%	Shares
Longaeva Partners L.P.	$12,286,650	163,822	0.47%	Shares
RHUMBLINE ADVISERS	$10,812,225	144,163	0.42%	Shares
AMERICAN CENTURY COMPANIES INC	$10,613,250	141,510	0.41%	Shares
Balyasny Asset Management L.P.	$10,123,575	134,981	0.39%	Shares
RENAISSANCE TECHNOLOGIES LLC	$9,750,000	130,000	0.37%	Shares
Point72 Asset Management, L.P.	$8,192,700	109,236	0.31%	Shares
Verition Fund Management LLC	$7,913,100	105,508	0.30%	Shares
ARIEL INVESTMENTS, LLC	$7,569,975	100,933	0.29%	Shares
MILLENNIUM MANAGEMENT LLC	$7,500,000	100,000	0.29%	Call option
KESTREL INVESTMENT MANAGEMENT CORP	$7,305,000	97,400	0.28%	Shares
Divisadero Street Capital Management, LP	$7,234,425	96,459	0.28%	Shares
Swiss National Bank	$6,997,500	93,300	0.27%	Shares
GOLDMAN SACHS GROUP INC	$6,750,000	90,000	0.26%	Call option
GOLDMAN SACHS GROUP INC	$6,750,000	90,000	0.26%	Put option
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$6,510,000	86,800	0.25%	Call option
Squarepoint Ops LLC	$6,459,300	86,124	0.25%	Shares
RAYMOND JAMES FINANCIAL INC	$6,215,025	82,867	0.24%	Shares
Quantinno Capital Management LP	$5,477,550	73,034	0.21%	Shares
ROYCE & ASSOCIATES LP	$5,360,625	71,475	0.21%	Shares
AMERIPRISE FINANCIAL INC	$5,358,525	71,447	0.21%	Shares
JUPITER ASSET MANAGEMENT LTD	$5,229,300	69,724	0.20%	Shares
ALLIANCEBERNSTEIN L.P.	$5,166,634	91,672	0.20%	Shares
SEGALL BRYANT & HAMILL, LLC	$5,106,900	68,092	0.20%	Shares
AMERICAN CAPITAL MANAGEMENT INC	$5,018,625	66,915	0.19%	Shares
ISTHMUS PARTNERS, LLC	$4,946,325	65,951	0.19%	Shares
Corient Private Wealth LP	$4,851,975	64,693	0.19%	Shares
FIRST TRUST ADVISORS LP	$4,751,850	63,358	0.18%	Shares
DEAN INVESTMENT ASSOCIATES, LLC	$4,649,175	61,989	0.18%	Shares
PEREGRINE CAPITAL MANAGEMENT LLC	$4,497,450	59,966	0.17%	Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$4,484,325	59,791	0.17%	Shares
Bridgewater Associates, LP	$4,479,975	59,733	0.17%	Shares
ENVESTNET ASSET MANAGEMENT INC	$4,181,475	55,753	0.16%	Shares
Trexquant Investment LP	$3,946,425	52,619	0.15%	Shares
Aequim Alternative Investments LP	$3,840,000	51,200	0.15%	Shares
RICE HALL JAMES & ASSOCIATES, LLC	$3,827,850	51,038	0.15%	Shares
JANE STREET GROUP, LLC	$3,682,500	49,100	0.14%	Call option
MetLife Investment Management, LLC	$3,681,075	49,081	0.14%	Shares
BlackRock, Inc.	$3,618,975	48,253	0.14%	Shares
Retirement Systems of Alabama	$3,604,875	48,065	0.14%	Shares
Riverwater Partners LLC	$3,573,375	47,645	0.14%	Shares
Skylands Capital, LLC	$3,571,875	47,625	0.14%	Shares
FIFTH THIRD BANCORP	$3,561,472	47,486	0.14%	Shares
ALGERT GLOBAL LLC	$3,522,750	46,970	0.14%	Shares
STATE OF WISCONSIN INVESTMENT BOARD	$3,441,750	45,890	0.13%	Shares
Qube Research & Technologies Ltd	$3,425,475	45,673	0.13%	Shares
Dean Capital Management	$3,372,600	44,968	0.13%	Shares
VANGUARD ASSET MANAGEMENT, Ltd	$3,351,375	44,685	0.13%	Shares
EASTERLY INVESTMENT PARTNERS LLC	$3,248,025	43,307	0.12%	Shares
Phocas Financial Corp.	$3,227,250	43,030	0.12%	Shares
ZB,N.A.	$3,200,968	40,996	0.12%	Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$3,190,200	42,536	0.12%	Shares
CONNORS INVESTOR SERVICES INC	$3,150,000	42,000	0.12%	Shares
Expect Equity LLC	$3,076,950	41,026	0.12%	Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$2,964,874	52,606	0.11%	Shares
BEACON INVESTMENT ADVISORS LLC	$2,783,648	37,115	0.11%	Shares
Campbell & CO Investment Adviser LLC	$2,763,300	36,844	0.11%	Shares
Assenagon Asset Management S.A.	$2,633,175	35,109	0.10%	Shares
BARCLAYS PLC	$2,448,300	32,644	0.09%	Shares
MARSHALL WACE, LLP	$2,286,975	30,493	0.09%	Shares
Cubist Systematic Strategies, LLC	$2,219,702	45,541	0.09%	Shares
XTX Topco Ltd	$2,208,150	29,442	0.08%	Shares
Legal & General Group Plc	$2,032,875	27,105	0.08%	Shares
CARY STREET PARTNERS FINANCIAL LLC	$1,999,800	26,664	0.08%	Shares
Nierenberg Investment Management Company, LLC	$1,971,000	26,280	0.08%	Shares
Aurora Investment Counsel	$1,912,575	25,501	0.07%	Shares
WESBANCO BANK INC	$1,912,500	25,500	0.07%	Shares
Cardinal Capital Management	$1,861,275	24,817	0.07%	Shares
NEW YORK STATE COMMON RETIREMENT FUND	$1,846,275	24,617	0.07%	Shares
Legato Capital Management LLC	$1,758,750	23,450	0.07%	Shares
CITADEL ADVISORS LLC	$1,740,000	23,200	0.07%	Call option

Company insiders 72 insiders · 48 officers · 25 directors

Insider	Role	Last activity	Shares owned	Buys 12m	Net 12m
Christopher Simon,	President & CEO	May 15, 2026 A	444,704	0	$0
Brian Concannon	President & CEO	Sept. 15, 2015 M	147,040	0	$0
James Darecca	EVP, Chief Financial Officer	May 15, 2026 A	54,444	0	$0
William P. Mr. Burke	EVP, Chief Financial Officer	Aug. 23, 2021 M	30,291	0	$0
Christopher J Lindop	CFO & EVP Business Development	Jan. 13, 2016 A	56,743	0	$0
Ronald J Ryan	VP and CFO	Nov. 1, 2006 P	2,101	0	$0
Stewart W Strong	President, Global Hospital	July 26, 2024 S	18,196	0	$0
Byron Selman	President, Global Markets	Oct. 25, 2016 A	23,318	0	$0
Peter M Allen	President, Global Plasma	July 6, 2015 M	34,102	0	$0
Kelly Michael P	President, Global Markets	Nov. 11, 2013 M	10,987	0	$0
Mikael Gordon	President, Global Markets	May 3, 2012 M	4,442	0	$0
Remi Corlin	President, Asia	Aug. 8, 2008 M	884	0	$0
Keiko Hattori	President, Haemonetics Japan	May 1, 2008 P	716	0	$0
Thomas Lawlor	President, Patient Division	Nov. 28, 2007 M	0	0	$0
Ryoji Sakai	President, Japan	June 14, 2007 M	0	0	$0
Ulrich Eckert	President, Europe & Latin Am	Nov. 1, 2006 P	890	0	$0
Yutaka Sakurada	President, Japan & Asia	May 2, 2005 P	2,347	0	$0
Frank Chan	EVP, Chief Operating Officer	May 15, 2026 A	32,936	0	$0
Kent J Davies	Chief Operating Officer	Oct. 23, 2015 S	16,891	0	$0
Farris Maryanne Maunsell	VP, Chief Accounting Officer	June 5, 2026 F	6,242	0	$0
Laurie A. Miller	SVP, Human Resources	June 5, 2026 F	40,987	0	$0
Roy Galvin	EVP, Chief Commercial Officer	May 15, 2026 A	39,882	0	$0
Michelle L Basil	EVP and General Counsel	May 15, 2026 A	68,829	0	$0
Anila Lingamneni	EVP, Chief Technology Officer	July 12, 2024 S	21,331	0	$0
Josep Llorens	EVP, Global Manufacturing	May 28, 2024 F	30,940	0	$0
Dan Goldstein	VP, Corporate Controller	June 13, 2022 S	4,447	0	$0
Jacqueline Scanlan	SVP, Global Human Resources	June 7, 2021 S	4,216	0	$0
Said Bolorforosh	EVP, Chief Technology Officer	Nov. 11, 2019 S	1,977	0	$0
Neil 122-62-507 Ryding	EVP, Global Manufacturing	June 7, 2018 S	15,226	0	$0
David Fusco	EVP, Global Human Resources	Oct. 25, 2016 A	16,867	0	$0
Sandra Jesse	EVP and Chief Legal Officer	Oct. 25, 2016 A	48,166	0	$0
Jonathan White	Chief Science and Technology	Oct. 26, 2015 S	30,507	0	$0
Susan M Hanlon	VP Finance	Oct. 26, 2015 S	20,464	0	$0
Brian R Burns	EVP, Global QA/RA	Oct. 23, 2015 S	16,235	0	$0
Dave Helsel	EVP, Global Manufacturing	April 13, 2015 D	13,216	0	$0
Kathleen Mcdaniel	EVP Global Human Resources	Aug. 28, 2014 S	5,013	0	$0
Warren Nighan JR	EVP, Global QA/RA	July 24, 2013 A	7,618	0	$0
Joseph J Forish	VP, Human Resources	April 30, 2013 P	17,279	0	$0
Phillip John Brancazio	VP, Global Manufacturing	May 4, 2011 P	3,052	0	$0
Alicia R Lopez	VP, Corporate Affairs	April 5, 2011 D	2,815	0	$0
Michael I Ruxin	VP Global Software Strategies	Nov. 4, 2010 P	215	0	$0
Brad Nutter	Chairman of the Board	July 29, 2010 A	10,580	0	$0
Robert B Ebbeling	Vice President, Operations	May 1, 2009 P	15,849	0	$0
Jan Conneely	VP & GM, Arryx, Inc.	May 1, 2008 P	1,041	0	$0
William Granville	VP, Manufacturing	May 1, 2008 P	12,188	0	$0
Mark A Popovsky	VP, Corporate Medical Director	May 1, 2008 P	4,891	0	$0
Stephen Swenson	VP & General Mgr, Global Plasm	May 1, 2008 P	3,024	0	$0
William Roche Still	VP & Gen Mrg, Therapeutics Bus	May 4, 2007 M	4,193	0	$0
Lloyd Emerson Johnson	Director	July 24, 2026 A	15,471	0	$0
Diane M Bryant	Director	July 24, 2026 A	9,664	0	$0
Claire Pomeroy	Director	July 24, 2026 A	19,410	0	$0
Ellen M Zane	Director	July 24, 2026 A	21,911	0	$0
Martin D Madaus	Director	July 24, 2026 A	2,538	0	$0
Mark W Kroll	Director	July 24, 2026 A	27,295	1	$98,784
Michael J Coyle	Director	July 24, 2026 A	17,932	0	$0
Robert E Abernathy	Director	July 24, 2026 A	27,519	0	$0
Charles J Dockendorff	Director	July 24, 2025 A	7,126	0	$0
Catherine M Burzik	Director	Aug. 5, 2022 A	19,545	0	$0
Richard J Meelia	Director	Feb. 4, 2021 M	32,050	0	$0
Ronald G Gelbman	Director	Nov. 11, 2019 M	48,384	0	$0
Pedro P Granadillo	Director	Nov. 8, 2018 S	15,335	0	$0
Susan Bartlett Foote	Director	Nov. 10, 2017 M	20,740	0	$0
Ronald Merriman	Director	May 22, 2017 M	17,807	0	$0
Lawrence C Best	Director	June 12, 2014 M	10,001	0	$0
Paul Black	Director	July 24, 2013 A	8,981	0	$0
Ronald A Matricaria	Director	May 5, 2006 A	—	0	$0
Benjamin L Holmes	Director	Jan. 31, 2005 M	—	0	$0
Donna C E Williamson	Director	June 23, 2004 M	1,300	0	$0
Harvey G Klein	Director	May 5, 2004 A	—	0	$0
Anthony Pare	—	June 30, 2008 M	2,523	0	$0
James O'Shaughnessy	—	May 1, 2008 P	3,781	0	$0
Mark Beucler	—	May 1, 2008 P	1,989	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 8 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	Feb. 6, 2004	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	Aug. 20, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	Aug. 8, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 24, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 19, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 3, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	May 27, 2003	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 15, 2001	—	Initial filing	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 88 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
NBSM · Neuberger Berman ETF Trust	1.86%	61,981 NS	May 31, 2026	N-PORT
JSML · Janus Detroit Street Trust	0.84%	43,927 NS	April 30, 2026	N-PORT
JSMD · Janus Detroit Street Trust	0.77%	125,093 NS	April 30, 2026	N-PORT
ROSC · Lattice Strategies Trust	0.64%	5,836 NS	April 30, 2026	N-PORT
SIXL · EXCHANGE TRADED CONCEPTS TRUST	0.46%	12,701 NS	May 31, 2026	N-PORT
PSC · Principal Exchange-Traded Funds	0.36%	110,180 NS	June 30, 2026	N-PORT
CALF · Pacer Funds Trust	0.35%	201,070 NS	April 30, 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0.32%	35,814 NS	May 31, 2026	N-PORT
ABCS · EA Series Trust	0.31%	522 NS	May 29, 2026	N-PORT
IWO · iShares Trust	0.28%	404,519 SH	Aug. 19, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.28%	75,696 SH	Aug. 19, 2026	Daily
FYC · First Trust Exchange-Traded AlphaDE…	0.24%	41,437 NS	April 30, 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0.20%	47,624 SH	Aug. 19, 2026	Daily
AVSC · AMERICAN CENTURY ETF TRUST	0.19%	76,694 NS	May 31, 2026	N-PORT
IWM · iShares Trust	0.15%	1,212,781 SH	Aug. 19, 2026	Daily
PKW · Invesco Exchange-Traded Fund Trust	0.14%	24,474 SH	Aug. 19, 2026	Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0.14%	17,393 NS	April 30, 2026	N-PORT
MIDE · DBX ETF Trust	0.13%	63 NS	May 29, 2026	N-PORT
QVMM · Invesco Exchange-Traded Fund Trust …	0.13%	5,332 SH	Aug. 19, 2026	Daily
BKSE · BNY Mellon ETF Trust	0.13%	1,703 NS	April 30, 2026	N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr…	0.12%	12,097 NS	April 30, 2026	N-PORT
SMDX · Tidal Trust III	0.12%	2,419 NS	April 30, 2026	N-PORT
IVOG · VANGUARD ADMIRAL FUNDS	0.11%	27,512 SH	Aug. 19, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.11%	271,486 SH	Aug. 19, 2026	Daily
NUSC · Nushares ETF Trust	0.11%	23,551 NS	April 30, 2026	N-PORT
FSMD · FIDELITY COVINGTON TRUST	0.11%	42,163 NS	April 30, 2026	N-PORT
ESML · iShares Trust	0.11%	29,234 SH	Aug. 19, 2026	Daily
IVOO · VANGUARD ADMIRAL FUNDS	0.10%	74,976 SH	Aug. 19, 2026	Daily
FNDA · SCHWAB STRATEGIC TRUST	0.10%	126,817 NS	May 31, 2026	N-PORT
ISCV · iShares Trust	0.09%	6,131 SH	Aug. 19, 2026	Daily
EBIT · Harbor ETF Trust	0.09%	168 NS	April 30, 2026	N-PORT
RSSL · Global X Funds	0.09%	20,324 NS	April 30, 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0.08%	15,968 SH	Aug. 19, 2026	Daily
ITWO · ProShares Trust	0.08%	2,210 NS	May 31, 2026	N-PORT
PTMC · Pacer Funds Trust	0.08%	5,212 NS	April 30, 2026	N-PORT
ISCB · iShares Trust	0.07%	2,011 SH	Aug. 19, 2026	Daily
RWK · Invesco Exchange-Traded Fund Trust …	0.07%	9,034 SH	Aug. 19, 2026	Daily
DFAS · Dimensional ETF Trust	0.07%	159,737 NS	April 30, 2026	N-PORT
MVV · ProShares Trust	0.07%	1,606 NS	May 31, 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0.07%	222,776 NS	May 31, 2026	N-PORT
FYX · First Trust Exchange-Traded AlphaDE…	0.06%	12,283 NS	April 30, 2026	N-PORT
ISCG · iShares Trust	0.06%	5,390 SH	Aug. 19, 2026	Daily
MIDU · Direxion Shares ETF Trust	0.06%	770 NS	April 30, 2026	N-PORT
FSCC · Federated Hermes ETF Trust	0.05%	2,220 NS	May 31, 2026	N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST	0.05%	1,979 NS	May 31, 2026	N-PORT
VBK · VANGUARD INDEX FUNDS	0.05%	302,003 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.05%	139,826 SH	Aug. 19, 2026	Daily
FAD · First Trust Exchange-Traded AlphaDE…	0.05%	3,866 NS	April 30, 2026	N-PORT
UMDD · ProShares Trust	0.05%	224 NS	May 31, 2026	N-PORT
UWM · ProShares Trust	0.05%	1,729 NS	May 31, 2026	N-PORT
WSML · iShares Trust	0.05%	3,008 SH	Aug. 19, 2026	Daily
DFAT · Dimensional ETF Trust	0.05%	105,201 NS	April 30, 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0.05%	21,461 NS	April 30, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.04%	533,077 SH	Aug. 19, 2026	Daily
VB · VANGUARD INDEX FUNDS	0.04%	1,042,525 SH	Aug. 19, 2026	Daily
VBR · VANGUARD INDEX FUNDS	0.04%	331,074 SH	Aug. 19, 2026	Daily
GSSC · Goldman Sachs ETF Trust	0.04%	5,317 NS	May 31, 2026	N-PORT
URTY · ProShares Trust	0.03%	1,750 NS	May 31, 2026	N-PORT
AVSU · AMERICAN CENTURY ETF TRUST	0.03%	2,270 NS	May 31, 2026	N-PORT
EBI · RBB Fund Trust	0.03%	2,598 NS	May 31, 2026	N-PORT
TILT · FlexShares Trust	0.03%	8,470 NS	April 30, 2026	N-PORT
AVUS · AMERICAN CENTURY ETF TRUST	0.02%	44,580 NS	May 31, 2026	N-PORT
DXUV · Dimensional ETF Trust	0.02%	1,323 NS	April 30, 2026	N-PORT
IWN · iShares Trust	0.02%	24,298 SH	Aug. 19, 2026	Daily
DFUV · Dimensional ETF Trust	0.02%	40,040 NS	April 30, 2026	N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe…	0.01%	395 SH	Aug. 19, 2026	Daily
HDG · ProShares Trust	0.01%	44 NS	May 31, 2026	N-PORT
DCOR · Dimensional ETF Trust	0.01%	6,668 NS	April 30, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.01%	97,492 NS	April 30, 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0.01%	2,320 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.01%	10,376 SH	Aug. 19, 2026	Daily
IUSG · iShares Trust	0.01%	23,949 SH	Aug. 19, 2026	Daily
DFSU · Dimensional ETF Trust	0.01%	2,539 NS	April 30, 2026	N-PORT
IWV · iShares Trust	0.01%	13,976 SH	Aug. 19, 2026	Daily
ITOT · iShares Trust	0.01%	61,373 SH	Aug. 19, 2026	Daily
FNDB · SCHWAB STRATEGIC TRUST	0.01%	1,282 NS	May 31, 2026	N-PORT
IUSV · iShares Trust	0.01%	16,191 SH	Aug. 19, 2026	Daily
DFAU · Dimensional ETF Trust	0.01%	11,534 NS	April 30, 2026	N-PORT
DFUS · Dimensional ETF Trust	0.00%	14,005 NS	April 30, 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0.00%	26,981 NS	May 31, 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0.00%	1,441,997 SH	Aug. 19, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.00%	37,682 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	3,899 SH	Aug. 19, 2026	Daily
IJH · iShares Trust	—	1,608,447 SH	Aug. 19, 2026	Daily
IJK · iShares Trust	—	162,796 SH	Aug. 19, 2026	Daily
IJJ · iShares Trust	—	94,696 SH	Aug. 19, 2026	Daily
XJH · iShares Trust	—	6,299 SH	Aug. 19, 2026	Daily
SMLF · iShares Trust	—	28,821 SH	Aug. 19, 2026	Daily

About Haemonetics Corporation Common Stock Company overview from Wikipedia

History

Product categories

Hemostasis

HAE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

HAE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

HAE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

Institutional owners (13F) 363 filers · $2.6B total · As of June 30, 2026

Company insiders 72 insiders · 48 officers · 25 directors

Activists & 5%+ owners 8 positions

ETF ownership Held by 88 ETFs